These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

453 related items for PubMed ID: 16757924

  • 21. Progressive hearing loss after completion of cisplatin chemotherapy is common and more pronounced in children without spontaneous otoacoustic emissions before chemotherapy.
    Weissenstein A, Deuster D, Knief A, Zehnhoff-Dinnesen AA, Schmidt CM.
    Int J Pediatr Otorhinolaryngol; 2012 Jan; 76(1):131-6. PubMed ID: 22104469
    [Abstract] [Full Text] [Related]

  • 22. Cisplatin ototoxicity in the Sprague Dawley rat evaluated by distortion product otoacoustic emissions.
    Hatzopoulos S, Di Stefano M, Campbell KC, Falgione D, Ricci D, Rosignoli M, Finesso M, Albertin A, Previati M, Capitani S, Martini A.
    Audiology; 2001 Jan; 40(5):253-64. PubMed ID: 11688544
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
    Hoth S.
    Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
    [Abstract] [Full Text] [Related]

  • 26. Ototoxicity of high-dose cisplatin by bolus administration in patients with advanced cancers and normal hearing.
    Kopelman J, Budnick AS, Sessions RB, Kramer MB, Wong GY.
    Laryngoscope; 1988 Aug; 98(8 Pt 1):858-64. PubMed ID: 3398663
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Distortion product otoacoustic emissions as a prognostic factor for idiopathic sudden sensorineural hearing loss.
    Chao TK, Chen TH.
    Audiol Neurootol; 2006 Aug; 11(5):331-8. PubMed ID: 16983184
    [Abstract] [Full Text] [Related]

  • 30. Cisplatin-induced long-term hearing impairment is associated with specific glutathione s-transferase genotypes in testicular cancer survivors.
    Oldenburg J, Kraggerud SM, Cvancarova M, Lothe RA, Fossa SD.
    J Clin Oncol; 2007 Feb 20; 25(6):708-14. PubMed ID: 17228018
    [Abstract] [Full Text] [Related]

  • 31. Ototoxicity screening of patients treated with streptomycin using distortion product otoacoustic emissions.
    Md Daud MK, Mohamadl H, Haron A, Rahman NA.
    B-ENT; 2014 Feb 20; 10(1):53-8. PubMed ID: 24765829
    [Abstract] [Full Text] [Related]

  • 32. Ear canal pressure variations versus negative middle ear pressure: comparison using distortion product otoacoustic emission measurement in humans.
    Sun XM.
    Ear Hear; 2012 Feb 20; 33(1):69-78. PubMed ID: 21747284
    [Abstract] [Full Text] [Related]

  • 33. Protective effects of vitamins E, B and C and L-carnitine in the prevention of cisplatin-induced ototoxicity in rats.
    Tokgöz SA, Vuralkan E, Sonbay ND, Çalişkan M, Saka C, Beşalti Ö, Akin İ.
    J Laryngol Otol; 2012 May 20; 126(5):464-9. PubMed ID: 22490890
    [Abstract] [Full Text] [Related]

  • 34. Prophylactic etanercept treatment in cisplatin ototoxicity.
    Dasli S, Topdag M, Mutlu A, Kara A, Ozturk M.
    Eur Arch Otorhinolaryngol; 2017 Oct 20; 274(10):3577-3583. PubMed ID: 28730299
    [Abstract] [Full Text] [Related]

  • 35. Distortion product otoacoustic emissions in an industrial setting.
    Korres GS, Balatsouras DG, Tzagaroulakis A, Kandiloros D, Ferekidou E, Korres S.
    Noise Health; 2009 Oct 20; 11(43):103-10. PubMed ID: 19414930
    [Abstract] [Full Text] [Related]

  • 36. [Hearing assessment of children treated with Cisplatin].
    Mniszek J, Bielecki I, Sobol G.
    Pol Merkur Lekarski; 2009 Aug 20; 27(158):105-8. PubMed ID: 19856874
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Recovery from cisplatin-induced ototoxicity: a case report and review.
    Truong MT, Winzelberg J, Chang KW.
    Int J Pediatr Otorhinolaryngol; 2007 Oct 20; 71(10):1631-8. PubMed ID: 17706797
    [Abstract] [Full Text] [Related]

  • 39. Ototoxic impact of cisplatin in pediatric oncology patients.
    Berg AL, Spitzer JB, Garvin JH.
    Laryngoscope; 1999 Nov 20; 109(11):1806-14. PubMed ID: 10569412
    [Abstract] [Full Text] [Related]

  • 40. ABR obtained from time-efficient train stimuli for cisplatin ototoxicity monitoring.
    Dille MF, Ellingson RM, McMillan GP, Konrad-Martin D.
    J Am Acad Audiol; 2013 Oct 20; 24(9):769-81. PubMed ID: 24224985
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.